Idiopathic dilated cardiomyopathy (DCM) is a heritable, genetically heterogeneous disorder that causes progressive human heart failure and death. Candidate gene and family-based mapping studies have uncovered defects in diverse molecular pathways, yet DCM remains an idiopathic condition in the vast majority of patients. This proposal is based on recruitment and phenotypic characterization of a large cohort of unrelated subjects with DCM, including multigenerational families and multiple children with early-onset heart failure.
The first aim i s to identify novel genes for autosomal dominant DCM by combined genetic linkage and exome sequencing strategies.
The second aim i s to identify inherited and de novo mutations that underlie pediatric DCM.
The third aim i s to determine the frequency and spectrum of mutations in novel DCM genes in a well-characterized cohort.
These aims are designed to overcome existing technological barriers to DCM gene discovery by capitalizing on the emerging technology of whole-exome sequencing. The overall objectives of this work are to provide new insight into the molecular basis of myopathic heart failure, advance knowledge of the genetic basis of pediatric-onset DCM, and improve prediction, prevention, and treatment of DCM.

Public Health Relevance

Dilated cardiomyopathy (DCM) is a major public health problem, resulting in heart failure, arrhythmia, and death. DCM is the most common reason for cardiac transplantation, due to lack of diagnostic tests for early detection and ineffective treatments for advanced disease. Discovering the genetic basis of DCM will lead to better ways to diagnose and prevent the progressive weakening of heart muscle that afflicts patients with this disorder.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL071225-09A1
Application #
8367667
Study Section
Genetics of Health and Disease Study Section (GHD)
Program Officer
Fabsitz, Richard
Project Start
2002-07-15
Project End
2016-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
9
Fiscal Year
2012
Total Cost
$357,750
Indirect Cost
$132,750
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Theis, Jeanne L; Zimmermann, Michael T; Larsen, Brandon T et al. (2014) TNNI3K mutation in familial syndrome of conduction system disease, atrial tachyarrhythmia and dilated cardiomyopathy. Hum Mol Genet 23:5793-804
Terzic, Andre; Alekseev, Alexey E; Yamada, Satsuki et al. (2011) Advances in cardiac ATP-sensitive K+ channelopathies from molecules to populations. Circ Arrhythm Electrophysiol 4:577-85
Olson, Timothy M; Terzic, Andre (2010) Human K(ATP) channelopathies: diseases of metabolic homeostasis. Pflugers Arch 460:295-306
Brauch, Katharine M; Karst, Margaret L; Herron, Kathleen J et al. (2009) Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol 54:930-41
Reyes, Santiago; Terzic, Andre; Mahoney, Douglas W et al. (2008) K(ATP) channel polymorphism is associated with left ventricular size in hypertensive individuals: a large-scale community-based study. Hum Genet 123:665-7
Menon, S C; Michels, V V; Pellikka, P A et al. (2008) Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. Clin Genet 74:445-54
Olson, Timothy M; Michels, Virginia V; Ballew, Jeffrey D et al. (2005) Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293:447-54
Bienengraeber, Martin; Olson, Timothy M; Selivanov, Vitaliy A et al. (2004) ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet 36:382-7